Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure ...

Many of the 17 million projected to lose Medicaid coverage will turn to struggling free health clinics. They need more ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...

Firms like Moderna that are rapidly adopting AI and will have a higher mix of AI software robots to humans in the future ...

Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago. Indeed, if you axed Moderna off your watchlist after the ...

Buying shares of beaten-down companies only makes sense if there are good reasons to expect them to bounce back. If that's not the case, stocks that may look cheap and attractive aren't actually so.

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...

Moderna has a deep pipeline of promising mRNA candidates that stand to boost business. Regeneron is looking at label ...

However, Richard Hughes IV, a lawyer at Epstein Becker & Green PC and former Moderna Inc. executive, said it would take time for the change to happen. The removal of financial protections for ...

Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates May 01, 2025 6:30 AM ET Moderna, Inc. (MRNA) ...